<DOC>
	<DOCNO>NCT00913198</DOCNO>
	<brief_summary>The main objective study assess biological activity CP-4126 patient advance pancreatic cancer . In addition , correlation hENT1 ( human equilibrative nucleoside transporter 1 ) overall survival study .</brief_summary>
	<brief_title>A Study CP-4126 Patients With Advanced Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Histological cytological confirm advanced pancreatic cancer* Not eligible curative resection Performance Status ( ECOG ) 02 Estimated life expectancy least 12 week Age ≥ 18 year Adequate haematological biological function : Neutrophils ≥ 1.5 x 109/L Platelets &gt; 100.0 x 109/L Hb ≥ 10 g/dL AST/ALT alkaline phosphatase ( ALP ) ≤ 2.5 x institutional upper limit normal ( ULN ) , liver metastasis AST/ALT ≤ 5 x institutional ULN ALP ≤ 4 x institutional ULN Bilirubin ≤ 1.5 time institutional ULN , liver metastasis ≤ 3 x institutional ULN Serum creatinine ≤ 1.5 time institutional ULN Signed inform consent Prior chemotherapy metastatic disease Symptomatic brain metastasis Participation another therapeutic clinical study within 30 day enrolment clinical study Requirement concomitant treatment nonpermitted medication , include high dos vitamin alternative drug History allergic reaction gemcitabine egg Presence serious concomitant systemic disorder incompatible clinical study ( e.g . uncontrolled intercurrent illness include ongoing active infection ) Presence significant central nervous system psychiatric disorder ( ) would hamper patient 's compliance Pregnant breastfeed woman Absence adequate contraception male female fertile patient duration study ; also three month last treatment Known positive status HIV Any reason , investigator 's opinion , patient participate study . Drug alcohol abuse Prior radical resection , exploratory laparotomy well palliative ( e.g bypass ) surgery allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Pancreas</keyword>
	<keyword>Advanced adenocarcinoma</keyword>
	<keyword>CP-4126</keyword>
</DOC>